Skip to main content
Premium Trial:

Request an Annual Quote

Krisztina Halasz, Anna Kapferer, Helena Lexander, Jeffrey Leathe

Premium
Ludesi said this week that it has hired three new application specialists: Krisztina Halasz, Anna Kapferer, and Helena Lexander.
 
Prior to joining Ludesi, Halasz served as account manager and product specialist at Bio-Rad Laboratories. Lexander came to Ludesi after working for GE Healthcare as a proteomics scientist focusing on two-dimensional gel electrophoresis. Kapferer was R&D engineer at Nonlinear Dynamics, where she designed and evaluated software technologies while also developing algorithms.
 

 
BioTrove has named Jeffrey Leathe as CFO and has charged him with overseeing IT infrastructure development. Leathe has experience in both large public companies and in start-ups, BioTrove said. He formerly was at Apogent, Prime Computer, and at Congoleum Industries.
 

He also is director and chairman of the audit committee for Bottomline Technologies and is a director of the Senator George J. Mitchell Research Scholarship Institute.

Filed under

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.